A Systematic Review of the Effects of Equol (Soy Metabolite) on Breast Cancer
Equol is a soy isoflavone metabolite that can be produced by intestinal bacteria. It is lipophilic and resembles natural oestrogens with an affinity to oestrogen receptors. This review is focused on how equol affects breast cancer, as evidenced by in vivo and in vitro studies. Equol is considered ch...
Main Authors: | Rafidah Hod, Sandra Maniam, Nurul Huda Mohd Nor |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/4/1105 |
Similar Items
-
Advances in equol production: Sustainable strategies for unlocking soy isoflavone benefits
by: Cecilia Ortiz, et al.
Published: (2024-01-01) -
Soy isoflavone supplementation increases equol-producing capability in postmenopausal women with osteopenia
by: Elly Herwana, et al.
Published: (2015-12-01) -
Soy isoflavone supplementation increases equol-producing capability in postmenopausal women with osteopenia
by: Elly Herwana, et al.
Published: (2012-08-01) -
A systematic review of the effects of Equol (Soy Metabolite) on breast cancer
by: Hod, Rafidah, et al.
Published: (2021) -
Bioavailability of isoflavones from soy products in equol producers and non-producers in Japanese women
by: Ayako Miura, et al.
Published: (2016-12-01)